Adapthealth (AHCO) revenue breakdown

Healthcare · Medical Devices · Market cap $813M

By segment, Sleep Health is the largest at 42% of fiscal 2025 revenue, growing 8% a year over 3 years.

By product, Sleep is the largest at 39% of fiscal 2023 revenue; Supplies to the home grew fastest, 123% a year over 4 years.

Revenue by segment

Fiscal years, as Adapthealth reports them in its 10-K filings; fiscal 2025 total $3.2B.

Segments2022202320242025Share
Sleep Health$1.1B$1.3B$1.3B$1.4B 42%
Respiratory Health$554M$615M$651M$691M 21%
Diabetes Health$687M$660M$614M$592M 18%
Wellness at Home$626M$634M$646M$583M 18%

Revenue by product

Fiscal years, as Adapthealth reports them in its 10-K filings; fiscal 2023 total $3.2B.

Products20192020202120222023Share
Sleep$305M$411M$891M$1.1B$1.2B 39%
Diabetes—$162M$541M$687M$660M 21%
Respiratory$87M$152M$458M$555M$599M 19%
Other$44M$71M$186M$262M$301M 9%
HME$85M$114M$210M$221M$207M 6%
Supplies to the home$8M$146M$168M$179M$192M 6%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AHCO.
Open AHCO in Investingly

Questions

Where does Adapthealth make its money?

In fiscal 2025, by segment: Sleep Health $1.4B, Respiratory Health $691M, Diabetes Health $592M, Wellness at Home $583M.

From Adapthealth's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.